Showing results (351-360 of 393) with videos related to
Sort By:
Pageof 40
The Journal of Investigative Dermatology|December 12, 2018
Identification of a Robust Methylation Classifier for Cutaneous Melanoma DiagnosisKathleen Conway, Sharon N Edmiston, Joel S Parker, et al.Arthritis and Rheumatism|February 2, 2008
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixtureLaura B Hughes, Dahliann Morrison, James M Kelley, et al.IEEE Journal of Translational Engineering in Health and Medicine|October 13, 2016
National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network: Advancing Precision MedicinePenny Ford Carleton, Steven Schachter, John A Parrish, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 5, 2021
Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM StudyDanielle R Davari, Irene Orlow, Peter A Kanetsky, et al.The Journal of Investigative Dermatology|May 13, 2018
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS SubtypesNancy E Thomas, Sharon N Edmiston, Irene Orlow, et al.The Journal of Investigative Dermatology|August 27, 2017
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in MelanomaNancy E Thomas, Sharon N Edmiston, Peter A Kanetsky, et al.Journal of Medicinal Chemistry|August 14, 2008
Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activitiesDehui Duan, Dina M Sigano, James A Kelley, et al.Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.Pageof 40